Medidata Solutions, Inc. (NASDAQ:MDSO) COO Michael L. Capone sold 5,000 shares of the business’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $74.53, for a total transaction of $372,650.00. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Medidata Solutions, Inc. (NASDAQ MDSO) traded down 2.03% during trading on Thursday, hitting $72.53. 305,030 shares of the company traded hands. The firm has a 50 day moving average of $77.60 and a 200 day moving average of $66.91. The firm has a market cap of $4.11 billion, a P/E ratio of 117.17 and a beta of 1.79. Medidata Solutions, Inc. has a one year low of $46.10 and a one year high of $85.92.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Tuesday, July 18th. The company reported $0.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.28 by $0.03. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. The company had revenue of $137.41 million for the quarter, compared to analyst estimates of $134.28 million. During the same quarter in the prior year, the business posted $0.24 EPS. Medidata Solutions’s quarterly revenue was up 19.9% on a year-over-year basis. On average, analysts expect that Medidata Solutions, Inc. will post $1.28 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Michael L. Capone Sells 5,000 Shares of Medidata Solutions, Inc. (MDSO) Stock” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/08/17/michael-l-capone-sells-5000-shares-of-medidata-solutions-inc-mdso-stock.html.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Alps Advisors Inc. raised its position in shares of Medidata Solutions by 0.3% in the second quarter. Alps Advisors Inc. now owns 8,430 shares of the company’s stock valued at $659,000 after buying an additional 22 shares during the period. 1st Global Advisors Inc. raised its position in shares of Medidata Solutions by 0.5% in the second quarter. 1st Global Advisors Inc. now owns 8,243 shares of the company’s stock valued at $645,000 after buying an additional 37 shares during the period. World Asset Management Inc raised its position in shares of Medidata Solutions by 1.2% in the second quarter. World Asset Management Inc now owns 3,528 shares of the company’s stock valued at $276,000 after buying an additional 43 shares during the period. State Board of Administration of Florida Retirement System raised its position in shares of Medidata Solutions by 0.3% in the second quarter. State Board of Administration of Florida Retirement System now owns 33,828 shares of the company’s stock valued at $2,645,000 after buying an additional 109 shares during the period. Finally, State of Alaska Department of Revenue raised its position in shares of Medidata Solutions by 2.2% in the first quarter. State of Alaska Department of Revenue now owns 6,080 shares of the company’s stock valued at $350,000 after buying an additional 130 shares during the period.

Several brokerages have recently issued reports on MDSO. Morgan Stanley boosted their price objective on shares of Medidata Solutions from $63.00 to $74.00 and gave the company an “overweight” rating in a research note on Friday, April 28th. Needham & Company LLC boosted their price objective on shares of Medidata Solutions from $65.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, April 27th. Piper Jaffray Companies boosted their price objective on shares of Medidata Solutions to $87.00 and gave the company an “overweight” rating in a research note on Friday, July 7th. Citigroup Inc. reissued a “buy” rating and set a $95.00 price objective (up from $94.00) on shares of Medidata Solutions in a research note on Monday, July 24th. Finally, BidaskClub raised shares of Medidata Solutions from a “hold” rating to a “buy” rating in a research note on Wednesday, June 21st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $78.17.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Insider Buying and Selling by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.